Related Experiment Video

Updated: Jul 3, 2026

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
05:02

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on: October 24, 2019

34.5K

Delirium Prevalence and Associated Risk Factors in Critically Ill Pediatric Oncology Patients: A Cross-Sectional

Najah Hasan1, Mohamed Khader2, Mays Basha3

  • 1King Hussein Cancer Center, Amman, Jordan.

Sage Open Pediatrics
|April 8, 2026
PubMed

Insights

Pediatric delirium is common in critically ill cancer patients. Younger age, longer intensive care unit stays, and higher acuity scores were linked to delirium in children.

Area of Science:

  • Pediatric Intensive Care
  • Pediatric Oncology
  • Neuroscience

Background:

  • Pediatric delirium is understudied in cancer patients.
  • Understanding delirium prevalence is crucial for critically ill children.

Purpose of the Study:

  • Evaluate pediatric delirium prevalence in pediatric intensive care unit (PICU) oncology patients in Jordan.
  • Identify factors associated with delirium in this population.

Main Methods:

  • Cross-sectional study of 165 pediatric oncology patients (1 month-18 years).
  • Delirium assessed twice daily using the Cornell Assessment of Pediatric Delirium (CAPD).
  • Demographic and clinical variables analyzed for associations with delirium.

Main Results:

  • Delirium occurred in 29% of patients.
  • Younger age (<5 years), prolonged PICU stay (>7 days), and higher night-shift acuity scores were significantly associated with delirium (P < .05).
  • Delirium was more frequent in patients receiving low-flow oxygen therapy.

Conclusions:

  • Delirium is common in critically ill pediatric oncology patients in the PICU.
  • Routine delirium screening with validated tools is important for this population.
Abstract

Keywords:
deliriumdelirium/diagnosisintensive care unitsneoplasmspediatricpediatricsprevalence

More Related Videos

Bovine Ovarian Cortex Tissue Culture06:32

Bovine Ovarian Cortex Tissue Culture

Published on: January 14, 2021

5.5K
Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software08:57

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software

Published on: September 4, 2021

4.6K

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...